Pacira BioSciences, Inc.
PCRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,432 | -$4,847 | $4,812 | $16,041 |
| Dep. & Amort. | $21,191 | $27,322 | $21,168 | $21,243 |
| Deferred Tax | $8,072 | $752 | $1,397 | $3,508 |
| Stock-Based Comp. | $13,978 | $15,472 | $14,553 | $12,266 |
| Change in WC | -$15,995 | -$38,202 | $1,224 | -$24,332 |
| Other Non-Cash | $28,156 | $11,515 | -$7,695 | $4,406 |
| Operating Cash Flow | $60,834 | $12,012 | $35,459 | $33,132 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,870 | -$2,697 | -$8,548 | -$2,118 |
| Net Acquisitions | $0 | $0 | -$16,702 | $0 |
| Inv. Purchases | -$38,765 | -$6,306 | -$69,629 | -$45,195 |
| Inv. Sales/Matur. | $86,249 | $71,166 | $69,250 | $46,945 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $43,614 | $62,163 | -$25,629 | -$368 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$205,236 | -$3,750 | -$2,813 | -$2,812 |
| Stock Issued | $0 | $1,569 | $0 | $0 |
| Stock Repurch. | -$50,041 | -$50,039 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,199 | -$5,285 | -$181 | $857 |
| Financing Cash Flow | -$257,476 | -$57,505 | -$2,994 | -$1,955 |
| Forex Effect | $133 | $204 | $0 | $0 |
| Net Chg. in Cash | -$152,895 | $16,874 | $6,836 | $30,809 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $300,484 | $283,610 | $276,774 | $245,965 |
| End Cash | $147,589 | $300,484 | $283,610 | $276,774 |
| Free Cash Flow | $56,964 | $9,315 | $26,911 | $31,014 |